Contents - Pharmacology, Mechanisms ![]()
Transport of Proteolytic Enzymes Across Caco-2 Cell Monolayers
Bock U., Kolac C., Borchard G., Koch K., Fuchs R., Streichhan P., Lehr C.-M.
Evidence that TGF-b should be a therapeutic target in diabetic
nephropathy
Border W.A., Noble N.A.
Intestinal absorption of undegraded proteins in men- presence of
bromelain in plasma after oral intake
Castell J.V., Friedrich G., Kuhn C.-S., Poppe G.E.
Polyenzyme preparations interrupt the autocrine loop of
TGFb production in melanoma cells by conversing a2Macroglobulin (a2M) in to the fast-form which binds TGF-beta irreversible
Desser, L., Herbacek, I., Zavadova, E., and Mohr, T.
Cytokine synthesis in human peripheral blood
mononuclear cells after oral administration of polyenzyme preparations
Desser L., Rehberger A., Kokron E., Paukovits W.
Safety and Tolerance of Phlogenzym® (MU-91418-1 and MU-91418-2)
Doenicke A.
Dose-related bioavailability of bromelain and trypsin after
repeated oral administration
Donath F., Mai I., Maurer A., Brockmöller J., Kuhn C.-S., Friedrich G., Roots I.
What is the Mechanism of „Immunonormalizing“ Effects of Proteolytic Enzyme Combination
Ferencik M.
Proteolytic Enzymes Modulate the Adhesion Molecule
CD44 on Malignant Cells in Vitro
Gebauer F., Micheel B., Stauder G., Ransberger K., Kunze R.
Bromelain proteases suppress growth, invasion and lung
metastasis of B16F10 mouse melanoma cells
Grabowska E., Eckert K., Fichtner I., Schultze-Forster K., Maurer H.R.
Bromelain treatment of human T cells removes CD44,
CD45RA, E2-MIC2, CD6, CD7, CD8, and Leu 8-LAM1 surface molecules and markedly enhances
CD2-mediated T cell activation
Hale L.P., Haynes B.F.
Immunomodulation by a2-macroglobulin and
a2-macroglobulin-proteinase complexes- the effect on the human T lymphocyte response
Heumann D., Vischer T.L.
Interactions between cytokines and a2-macroglobulin
James K.
Systemic enzyme therapy
Jezdinsky J.
Low-dose chymotrypsin treatment inhibits neutrophil migration
into sites of inflammation in vivo- effects on Mac-1 and MEL-14 adhesion protein
expression and function
Jutila M.A., Kishimoto T.K., Finken M.
Comparison of media conditions to expand TIL-derived
T-cell lines from patients with peritoneal carcinomatosis including serum free, rIFN-g and
polyenzyme preparation
Kim Y.M, Zavadova E., Loercher A., Freedman R.S.
Effect of complex enzyme preparations on the fibrinogen-fibrin
system
Kizim A.I.
Selective modulation of cell adhesion molecules on
lymphocytes by bromelain protease 5
Kleef R., Delohery T.M., Bovbjerg D.H.
Introduction to Oral Enzyme Therapy
Kleine M.W.
The tolerance of Mulsal® N (MU-692 603)
Kleine M.-W.
Pharmacological effect of Wobenzym on the blood coagulation
system
Korpan M.I., Korpan N.N., Tschekman I.S., Fialka V.
Down modulation and function of the CD44 adhesion molecule by
proteolytic enzymes
Kunze R., Gebauer F., Stauder G.
Enhanced production of interferon in whole blood cultures from
volunteers premedicated with complex of hydrolytic enzymes
Lackovic V., Rovensky J.
Oral bioavailability of bromelain and trypsin after repeated oral
administration of a commercial polyenzyme preparation
Mai I., Donath F., Maurer A., Bauer S., Roots I.
Administration of
proteolytic enzymes bromelain and trypsin diminish the number of CD4+ cells and
the interferon-g response in Peyer’s patches and spleen in endotoxemic balb-c
mice
Manhart N., Akomeah R., Bergmeister H., Spittler A., Ploner M., Roth E.
Inflammation Optimalizing and Immunonormalizing Effects of Combinations of Proteolytic Enzymes
Nouza
K., Nouza M.
Questions of resorption of enzyme macromolecules
Nouza K., Wald M.
Thrombin and trypsin regulate cellular response by specific receptors activation
Olejár T., Nouza K.
Thrombin and trypsin receptors- The same mechanism of signalling
on cellular surfaces
Olejár T., Nouza K.
Systemic administration of papain enhances proteolytic activity in some regions of excitotoxin-damaged rat brain
Pliss L., Lisy V., Kristofikova Z., Stastny F.
Modulation of autoimmunity to beta-cell antigens by proteases
Roep B.O., Van den Engel N.K., Halteren A.G.S., Duinkerken G., Martin S.
Interaction Between Proteases and Blood-Brain Barrier- Possible Sequellae for Clinical Praxis
Šastny
F., Pliss L., Höschl C.
Potential of Targeting Cell Surface CD44 Proteins with
Proteinases in Preventing Tumor Growth and Metastasis
Sy M.S., Liu D., Kogerman P., Culp L.A.
Modulation of the activation threshold for autoreactive T cells via
systemic enzyme therapy with Phlogenzym
Targoni O., Lehmann P.-V.
Complex formation of physiologically active components of
Wobe-Mugos with biomembrane components
Tschekman I.S., Bobkov V.N., Zagorodnyi M.I.
Biochemical mechanisms of therapeutic effect of complex enzyme
preparations
Veremeenko K.N.
The influence of human blood plasma inhibitors on the activity of serine and cysteine proteinases
Veremeenko K.N., Kizim A.I., Terzov A.I., Dosenko V.E., Nosenko O.A.
Systemic enzyme therapy, basic theoretical aspects, clinical application experience.
Veremeenko K.N., Kovalenko V.N.
Effects of single compounds used in oral enzyme therapy in
different in vitro and in vivo models of inflammation
Wood G.R., Ziska T., Morgenstern E., Stauder G.
Sequential effects of an oral enzyme combination with rutosid in
different in vitro and in vivo models of inflammation
Wood G.R., Ziska T., Morgenstern E., Stauder G.
Systemic Enzyme Therapy - Newest Status and Progress
Wrba H.
Proteolytic enzymes stimulate the cytotoxic
activity of human granulocytes in vitro and in vivo
Zavadova E., Desser L.
Inhalt - Pharmakologie, Mechanismen ![]()
Verträglichkeit von Mulsal® N (MU-692603)
Kleine M.-W.
Die Moleküle der Immunglobulin-Superfamilie - ein
zentraler Angriffspunkt der Enzymtherapie
Kunze R.
Enzyme als Immunmodulatoren
Menzel E.-J., Runge S.
Resorption partikulärer und makromolekularer Darminhaltsstoffe
Streichhan P., Pollinger W., Ransberger K.
Hydrolytische Serumaktivität und orale Enzymtherapie
Van Schaik W., Kleine M.-W.
Systemische Enzymtherapie - Aktueller Stand und Fortschritte
Wrba H.
Materials available only in Russian ![]()
Pharmacotherapy of rheumatoid arthritis
Kovalenko V.N.